Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

RMSSSHMP · Role of the mitochondrial sirtuins, SIRT3 and SIRT5, in hepatic metabolism and pathology

FP7Status: CLOSED1 February 201131 January 2013EU funding €173,565

The function of the three mitochondrial sirtuins SIRT3, 4, and 5 is poorly understood at present. As a limited number of studies have focused on SIRT3, its exact function and regulation in mammalian physiology need still to be elucidated. Likewise, beyond its recently discovered role in the regulation of carbamoyl phosphate synthase 1 (CPS1), nothing is known about the function of SIRT5, one of the other mitochondrial deacetylases from the sirtuin family. The present research project proposes to elucidate the function of SIRT3 and SIRT5 in the liver, a tissue in which both sirtuins are highly expressed. To accomplish this we will achieve the following specific aims: first, generating mice that lack SIRT3, SIRT5, and both SIRT3 and 5 specifically in hepatocytes. Second, evaluating how altering SIRT3 and/or SIRT5 expression levels specifically in liver can affect the hepatic and organismal response to metabolic stresses such as diets rich in carbohydrates and fat, in proteins, or in ethanol, whose metabolism takes place mostly in the mitochondria and, for the most part, in liver cells. Finally, we want to study whether SIRT3 and SIRT5 are involved in liver tumor development: exposure to different tumorigenic stimuli as alcohol-rich diets or certain mutagenic treatments leads to a change in SIRT3 and SIRT5 activity and cellular localization; all this points towards a possible function of these proteins in liver tumor development, an aspect we want to study in this project.We expect that our research will elucidate the basic function of hepatic SIRT3 and SIRT5 in metabolism and cancer. The outcome of our work will not only be useful from a fundamental scientific point of view, but it will also pave the way to new therapies that target SIRT3 and/or SIRT5 or the signaling pathways controlled by them in metabolic disease and hepatocarcinoma, ultimately improving healthspan and healthy aging.

Consortium · 1 organisation

coordinator

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

CH · €173,565

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.